Cite
HARVARD Citation
Weathers, S. et al. (2021). Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma. Neuro-oncology advances. 3 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Weathers, S. et al. (2021). Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma. Neuro-oncology advances. 3 (1), p. . [Online].